Magnetic nanoparticles could offer less invasive Parkinson’s treatment

By Published On: 19 November 2026
Magnetic nanoparticles could offer less invasive Parkinson’s treatment

Tiny magnetic particles have improved Parkinson’s-like movement problems in mice by stimulating deep brain regions without the need for permanently implanted electrodes.

The experimental technique uses magnetic fields to activate nerve cells in areas of the brain involved in movement, potentially offering an alternative to conventional deep brain stimulation.

Mice with Parkinson’s-like symptoms showed significant improvements in movement after treatment, although the approach has not yet been tested in humans.

An international research team involving Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), RWTH Aachen and the universities of Maastricht and Leuven developed the method using specially designed magnetic nanoparticles.

Parkinson’s disease develops when brain cells responsible for producing dopamine, a chemical messenger involved in controlling movement, gradually deteriorate.

As dopamine levels fall, communication within the brain’s movement circuits becomes disrupted, contributing to tremors and other movement difficulties.

Some patients receive deep brain stimulation, which involves surgically implanting electrodes into specific brain regions and connecting them to a device placed beneath the collarbone.

The electrodes deliver electrical signals to help regulate abnormal brain activity, but the procedure is complex, does not always work and is not suitable for everyone.

Professor Danijela Gregurec, from FAU’s Department of Chemistry and Pharmacy, said: “This puts many Parkinson’s patients off, and not all patients are suitable candidates for one of these pacemakers.

The experimental approach instead involves injecting magnetic nanoplatelets into the subthalamic nucleus, a brain region involved in controlling movement and a target for conventional deep brain stimulation.

When an external magnetic field is applied, the particles generate tiny mechanical forces that activate nearby nerve cells.

These forces slightly change the shape of nerve cell membranes, opening channels that respond to physical pressure.

The channels allow electrically charged particles, known as ions, to enter the cells and alter their electrical activity.

Gregurec explained: “In contrast, we use the neurons’ natural mechanosensors to influence regions deep within the brain.”

The researchers tested the approach in mice with damage to dopamine-producing nerve cells, causing movement difficulties resembling those associated with Parkinson’s.

They injected the particles directly into the animals’ subthalamic nucleus using a precision technique that guides instruments to specific locations within the brain.

After applying an external magnetic field, the researchers observed significant improvements in movement.

Gregurec said the effect was roughly equivalent to what the researchers would expect from an implanted brain pacemaker.

The particles remained in place throughout an observation period lasting several months, with no signs of inflammation detected.

However, the technique still requires an injection directly into the brain. The researchers are investigating ways to make the procedure less invasive.

One possibility is to develop particles that could be delivered through the bloodstream and cross the blood-brain barrier, the protective boundary that prevents many substances from entering brain tissue.

They are also exploring wearable devices that could generate the required magnetic fields, including a potential headband that patients could put on themselves.

These developments could eliminate the need for direct brain injections and make treatment more convenient and adjustable.

Gregurec said: “It is not only considerably simpler and cheaper than a conventional brain pacemaker, it is probably also more flexible. Adjusting the parameters of the magnetic field would allow us to control the nanoparticles more accurately.”

The technology could also give researchers another way to investigate how mechanical forces influence nerve cell activity.

Despite the improvements seen in mice, the approach remains experimental. Several more years of development are expected before it could be considered for clinical use.

£6.2 million investment to accelerate use of pioneering neurotechnology
Post